Lėtinio nuovargio sindromo diagnozė: kriterijai ir tolesni žingsniai

How is ME/CFS diagnosed in a clinical appointment?

The assessment has 2 parallel tracks: establishing whether the ME/CFS pattern is present and investigating other plausible causes. A normal panel completes neither track by itself; equally, finding a small laboratory abnormality does not automatically explain a profound decline in function or delayed crashes after ordinary activity.

A useful first appointment documents 3 anchors: what you could do before illness, what you can do now, and what happens afterward. Someone who still completes a work shift may nevertheless have substantial impairment if working consumes all available capacity and leaves them unable to cook, shower, or participate in family life.

I’m Thomas Klein, MD, Chief Medical Officer at Kantesti, and I would start with those functional questions rather than order an indiscriminate panel. Our organizacija ir tikslas explain the distinction between interpreting laboratory information and making a diagnosis that requires a clinical history, examination, and sometimes several appointments.

Kantesti yra AI kraujo tyrimo analizatorius that can help explain results used to investigate alternative causes of fatigue, but it cannot establish the required symptom pattern. As of October 23, 2026, this guide draws on NICE’s 2021 guideline and the National Academy of Medicine’s 2015 framework—not a purported new 2026 diagnostic blood test.

What are the National Academy of Medicine diagnostic criteria?

The fatigue must be of new or definite onset, not lifelong, not the result of ongoing excessive exertion, and not substantially relieved by rest. These qualifications distinguish the syndrome from simply feeling exhausted after an unusually demanding month; the 6-month requirement does not mean care should be withheld until the clock runs out.

The National Academy of Medicine report, published under the Institute of Medicine name, emphasizes symptom frequency and severity rather than a checklist of occasional experiences (Institute of Medicine, 2015). Having 1 bad night and occasional forgetfulness is not equivalent to recurrent, function-limiting symptoms throughout an otherwise typical week.

Consider an illustrative adult who has reduced paid work from 40 to 20 hours weekly, experiences delayed symptom worsening after meetings, and wakes unrefreshed despite adequate sleep opportunity. Cognitive slowing could satisfy the additional symptom domain; dizziness on standing would strengthen the assessment but is not mandatory under this framework.

A useful first laboratory assessment supports the search for competing explanations; it does not replace these clinical requirements. Bring a medication list and a brief account of symptom frequency over 2 representative weeks, including days when you deliberately did very little to avoid a crash.

Why do UK and US diagnostic timelines differ?

NICE advises suspecting ME/CFS after at least 6 weeks of symptoms in adults or 4 weeks in children and young people, provided the characteristic pattern and reduced function are present (NICE, 2021). Suspicion triggers investigation and support; it is not the same as a confirmed diagnosis or a reason to stop considering alternatives.

The 3-month and more-than-6-month thresholds are operational guideline choices, not evidence that a biological switch flips on a particular date. A clinician should record which framework they are using so that a later specialist, insurer, or school understands why the diagnosis was made and which symptoms were documented.

Children need an assessment of attendance, learning, social participation, and basic daily activities—not merely an adult questionnaire scaled down. A child attending school for 2 mornings weekly may appear outwardly engaged while needing prolonged recovery afterward; parents’ observations and the child’s own account can reveal different parts of the pattern.

Mūsų paaiškinimas apie pediatric interpretation limits addresses why age-specific laboratory ranges require care, but laboratory interpretation cannot replace pediatric assessment. Support at school and advice about avoiding symptom-provoking overexertion can begin during the initial 4-week or 6-week suspicion period, before diagnostic confirmation.

How do clinicians recognize post-exertional malaise?

PEM is more than muscle soreness or being pleasantly tired after exercise. A 20-minute conversation might be followed by intensified cognitive problems, sleep disturbance, pain, flu-like feelings, or reduced upright tolerance; the diagnostic clue is a disproportionate, multisymptom deterioration rather than the fact that activity used energy.

Ask about the day after the day after. A patient may feel reasonably capable during a supermarket trip yet spend the next 2 days recovering, so asking only whether they can shop misses the cost; repeated activity can also produce overlapping crashes that obscure any single trigger.

A 7–14-day activity-and-symptom diary can document the pattern without deliberately provoking it. Record the type of activity, approximate duration, immediate response, next-day response, and recovery time; our timeline interpretation guide explains a separate issue—why laboratory changes also need context rather than attribution to one event.

Two-day cardiopulmonary exercise testing is not required for routine ME/CFS diagnosis and can provoke substantial symptom worsening. It may have a role in selected specialist or disability assessments, but a clinician should discuss risks, practical benefit, and alternatives; a patient does not need to demonstrate a crash by pushing through a test.

What counts as substantial impairment of daily function?

Compare like with like over 2 periods: before illness and a representative current week. A former full-time worker managing 10 hours weekly has an obvious decline, but a caregiver maintaining essential tasks by abandoning leisure, relying on help, and resting between chores may have impairment that employment statistics completely miss.

Activity counts can underestimate illness when patients have already adapted successfully. Someone taking 3,000 steps daily without a conspicuous crash may be staying within a restricted energy limit; the absence of recent PEM during strict pacing does not establish that the underlying exertional intolerance has disappeared.

Clinicians also separate fatigue from weakness, breathlessness, and sleepiness because these suggest different investigations. Difficulty lifting a cup, falling asleep involuntarily, and feeling depleted after a shower are 3 different descriptions; asking the patient to demonstrate or describe the limitation can prevent an unhelpfully broad label of tiredness.

Treatable contributors still deserve attention when the ME/CFS pattern is convincing. For example, iron depletion before anemia can add to limited capacity, particularly with heavy menstrual loss; improvement after correcting low iron does not necessarily eliminate a separate pattern of delayed PEM and unrefreshing sleep.

How is unrefreshing sleep assessed without missing a sleep disorder?

A sleep history should cover bedtime, wake time, awakenings, snoring, witnessed breathing pauses, restless legs, and daytime sleep attacks. A 2-week sleep diary often clarifies whether the problem is insufficient opportunity, disrupted sleep, an irregular rhythm, or a persistent lack of restoration despite a reasonably consistent schedule.

Sleepiness and fatigue overlap, but they are not interchangeable. Someone who unintentionally falls asleep during a 15-minute quiet activity needs assessment for excessive daytime sleepiness; someone who remains awake but feels cognitively and physically depleted may need a different pathway, although both problems can occur together.

Mūsų sleep-study diagnostic pathway explains why narcolepsy testing requires careful preparation and specialist interpretation. Neither a normal overnight study nor a normal multiple sleep latency test rules out ME/CFS; these tests answer questions about sleep physiology, not the entire clinical syndrome.

Treat an identified sleep disorder and reassess the remaining symptom pattern rather than assuming 1 diagnosis explains everything. If effective apnea treatment improves alertness but a short outing still triggers a 48-hour multisymptom deterioration, the clinician should continue evaluating PEM and function instead of declaring the fatigue assessment finished.

Which cognitive symptoms support an ME/CFS diagnosis?

Ask for 2 concrete examples rather than accepting brain fog as a complete description. Losing track of a familiar recipe and needing repeated rereading of a short email reveal different limitations; examples also help clinicians distinguish processing difficulty from a language deficit, severe sleepiness, medication effects, or progressive neurological disease.

The conditions of testing matter. A 10-minute assessment in a quiet room after rest may look normal despite major difficulties during a noisy workday; clinicians can document this mismatch without asserting that every complaint requires formal neuropsychological testing or that a normal test means the symptoms are imagined.

Lifelong distractibility requires a developmental history, whereas new slowing after illness requires assessment of onset and associated symptoms. Our discussion of lifelong attention versus brain fog explains why 1 adult screening questionnaire cannot reliably resolve that distinction or establish the cause of a recent decline.

Sudden speech disturbance, new one-sided weakness, or acute confusion requires urgent assessment rather than attribution to ME/CFS. Gradual but progressive deterioration over 3–6 months also warrants reconsideration of alternatives; familiar brain fog should not become a catch-all explanation for a genuinely new neurological symptom.

How are orthostatic intolerance and POTS evaluated?

Adult POTS criteria include a sustained heart-rate rise of at least 30 beats/minute within 10 minutes upright; the threshold is at least 40 beats/minute for ages 12–19. The diagnosis also requires frequent orthostatic symptoms for at least 3 months, no significant orthostatic hypotension, and no other explanation for the tachycardia (Raj et al., 2022).

A blood-pressure fall of at least 20 mmHg systolic or 10 mmHg diastolic within 3 minutes of standing suggests classic orthostatic hypotension. These thresholds describe different physiological patterns; a single smartwatch pulse spike cannot determine which pattern is present or whether medication, dehydration, anemia, or thyroid disease is responsible.

Morning testing may reveal a stronger heart-rate response, and results can vary between visits. If a 10-minute stand is intolerable, stop and adapt the assessment rather than insisting on completion; people with severe ME/CFS may need shorter measurements, specialist advice, or home-based arrangements that minimize symptom worsening.

Mūsų palpitation assessment guide covers laboratory contributors, but an ECG and clinical examination may also be needed. Salt, fluid, compression, or medication advice should be individualized; a blanket instruction to drink 3 liters daily is inappropriate for someone with heart failure, kidney disease, or fluid restrictions.

Why can’t a routine blood test confirm ME/CFS?

A useful diagnostic biomarker must distinguish the target condition from realistic alternatives, not merely separate 2 small groups of patients and healthy volunteers. It also needs reproducible performance across laboratories and populations; an intriguing research signal may fail when compared with sleep disorders, long COVID, autoimmune disease, or medication-related fatigue.

Sensitivity and specificity depend on the intended use and the population tested. Even an apparently promising 90% specificity can create many false positives when used in a low-prevalence population; without independently validated clinical performance, a commercial score should not replace documented PEM, functional decline, and a proper differential assessment.

Kantesti yra AI kraujo tyrimo rezultatų interpretavimo platforma that explains laboratory findings; it does not turn normal results into a positive ME/CFS diagnosis. Our techniniai ir klinikiniai standartai should be considered separately from disease-specific validation: interpreting a thyroid result accurately is not evidence that an engine can diagnose ME/CFS.

Repeatedly ordering the same normal panel every 4 weeks rarely resolves an unchanged clinical question. Retesting becomes more useful when symptoms change, an abnormality needs follow-up, a treatment could affect results, or a new examination finding raises a different hypothesis; otherwise, the next step may be better history-taking rather than more samples.

Which baseline tests help assess alternative causes of fatigue?

Ferritin below 15 ng/mL strongly supports depleted iron stores in otherwise healthy adults, but inflammation can raise ferritin and conceal deficiency. The iron-study interpretation guide explains why transferrin saturation and clinical context may be needed; one result should not be treated as a universal threshold for every patient.

Thyroid interpretation usually begins with TSH, with free T4 added or interpreted according to the clinical situation. A mildly high TSH with normal free T4 does not automatically explain severe PEM; our tiroksino ir TSH paaiškinime helps distinguish overt dysfunction from a result that may require repeat testing.

B12 assessment becomes particularly relevant with dietary restriction, malabsorption risk, neuropathic symptoms, or macrocytosis; neurological deficiency can occur without anemia. A total B12 of 200–300 pg/mL may be considered borderline in some laboratories, and our ribinio B12 stebėjimo vadovas explains why assay ranges and confirmatory testing matter.

Kantesti can help organize these results alongside their units, laboratory intervals, and previous values, but the ordering clinician decides what is appropriate. Tell them about supplements, recent illness, and medications before the appointment; a 9 a.m. cortisol, for example, addresses selected adrenal concerns and is not a general test for stress or an ME/CFS confirmation test.

How do clinicians decide whether another diagnosis explains the symptoms?

A medication review should include prescriptions, over-the-counter products, supplements, alcohol, and other substances, with changes over the preceding 3 months. Sedating antihistamines, some pain medicines, and other drugs may impair alertness; beta-blockers can change pulse responses, complicating interpretation of an upright assessment without necessarily explaining delayed PEM.

Autoimmune testing becomes more useful when fatigue accompanies specific findings such as persistent joint swelling, photosensitive rash, Raynaud symptoms, or marked dryness. Our dryness and systemic symptom guide explains one relevant pathway; fatigue alone generally provides a weaker reason for broad antibody screening than fatigue plus 2 objective or characteristic features.

Depression deserves respectful assessment and treatment when present, but it should not be inferred from reduced activity alone. A person who wants to participate but develops a 2-day crash afterward presents a different clinical question from reduced motivation; mood symptoms and ME/CFS can coexist, and neither should erase the other.

New weight loss, persistent fever, abnormal examination findings, or progressive objective weakness shifts the differential away from uncomplicated fatigue. Ask whether an alternative explains 3 elements together—onset, symptom pattern, and trajectory—then reassess after appropriate treatment rather than assuming that a borderline laboratory result has settled the diagnosis.

When do infection and autoimmune antibody tests help?

EBV antibody testing distinguishes patterns of exposure; it is not a meter of ongoing fatigue severity. Our EBV antikūnų nustatymo vadovas explains VCA IgM, VCA IgG, and EBNA; more than 90% of adults have evidence of previous EBV infection, so a positive IgG alone is unsurprising.

ANA interpretation depends on method, titer, pattern, and compatible clinical findings. A result such as 1:80 does not establish lupus or explain PEM by itself; the ANA interpretation basics explain why a screening result may require no additional testing in one patient but targeted evaluation in another.

Long COVID and ME/CFS can overlap, particularly when delayed exertional worsening, unrefreshing sleep, and cognitive or orthostatic symptoms persist. Not everyone with long COVID meets ME/CFS criteria, and someone with 3 months of post-COVID symptoms may meet NICE’s timeline before meeting the National Academy of Medicine duration requirement.

Broad panels for multiple pathogens can create false leads when exposure risk is low and positive antibodies merely show past contact. Targeted testing should answer a specific question—such as a compatible illness after a tick exposure—rather than search for any positive result that might justify months of antimicrobial treatment without evidence of active infection.

What should happen after ME/CFS is suspected or diagnosed?

Energy management includes physical, cognitive, emotional, and social activity—not just steps or workouts. Splitting a 20-minute task into shorter parts may help, but there is no universal safe interval; decisions should follow the patient’s response, including symptoms appearing the following day rather than only during the task.

A practical follow-up plan names 3 things: who coordinates care, which symptoms or results will be reassessed, and when to seek earlier help. Patients with severe or very severe ME/CFS may need home visits, reduced sensory stimulation, mobility support, and help accessing nutrition; attendance at a distant clinic can itself be a major exertional load.

Supplements should address a demonstrated need or a carefully discussed symptom goal, not a promise to cure ME/CFS. Our lab-guided fatigue supplement discussion separates deficiency treatment from unsupported combinations; adding 5 products at once also makes side effects and any benefit harder to interpret.

Chest pain, severe breathlessness, fainting with concerning features, sudden neurological symptoms, or inability to maintain fluids requires urgent assessment rather than waiting for a routine follow-up. A new decline over 24–48 hours should be judged on its features and severity; a previous ME/CFS diagnosis does not protect someone from an unrelated acute illness.

Where does lab interpretation fit in the next-step care plan?

Kantesti yra AI pagrindu veikiantis kraujo tyrimų analizės įrankis that can explain uploaded laboratory reports and organize trends for discussion with a healthcare professional. Our Dirbtinio intelekto technologijos paaiškinimas describes the interpretation workflow; neither a report summary nor a risk score substitutes for documenting PEM and the applicable 3-month or more-than-6-month timeline.

Privacy matters when sharing a report that contains identifiers, dates of birth, or information about relatives. Review our informacija apie privatumą ir duomenis before uploading, and share only information you are authorized to provide; keeping 1 concise, relevant record is often more useful than circulating an entire medical history.

My practical advice as Thomas Klein, MD, is to ask 3 questions: Which diagnostic framework applies, what alternatives still need assessment, and what support can start now? Information about our medicinos konsultavimo komandą provides organizational context, but your own clinician must assess your symptoms and arrange a workable follow-up plan.

The 2 repository guides listed below are related educational publications, not peer-reviewed validation of an ME/CFS biomarker. The complement-testing clinical context concerns selected autoimmune questions. The Nipah diagnostikos mokomasis vadovas concerns a separate acute illness and is not a routine investigation for chronic fatigue.

Research publications and evidence boundaries

The 2 Zenodo records are presented as supplementary educational resources, separate from the directly relevant diagnostic references below. ResearchGate and Academia.edu links are title searches, not claims that verified copies exist on those services; neither repository publication supports diagnosing ME/CFS from routine laboratory results.

Dažnai užduodami klausimai